Aims Hypoxic ischaemic encephalopathy (HIE) remains a significant cause of long term
neurodisability despite therapeutic hypothermia (TH). Infants with mild HIE, representing …

Hypoxic–ischaemic encephalopathy (HIE) is a leading cause of acquired neonatal brain
injury. Assessment of the severity of cerebral injury and likely neurological outcome in …

A review of the conundrum called mild hypoxic-ischemic encephalopathy (HIE) is provided.
During the past decades, the definition of HIE has evolved to accommodate the short …

5. D'Alton GD, Berkowitz RL, Bienstock J, Ghidini A, Goldsmith J, Higgins R, et al. Executive
summary: neonatal encephalopathy and neurologic outcome, second edition–report of the …

Objective Hypoxic-ischaemic encephalopathy (HIE) remains a leading cause of neonatal
mortality and neurodisability. We aimed to determine the incidence of HIE and management …

Background The incidence of hypoxic-ischemic encephalopathy (HIE) is 0.5 per 1,000 live
births. Current standard treatment is therapeutic hypothermia (cooling) begun within 6 hours …

Background Therapeutic hypothermia (TH) is standard of care for moderate to severe
neonatal hypoxic ischemic encephalopathy (HIE) but many survivors still suffer lifelong …

METHODS: Secondary analysis of data from the multicenter randomized controlled trial of
longer, deeper, or usual care cooling in neonatal HIE (NCT01192776) that enrolled 364 …

Objective To compare the characteristics and outcomes of neonates with mild hypoxic-
ischemic encephalopathy (HIE) who received hypothermia versus standard care. Study …

Hypothermia treatment (HT) is now proven to be neuroprotective, is associated with
favourable outcomes, and is considered as the standard of care for moderate to severe …